US2020113915A1PendingUtilityA1
Methods and devices for capturing volatile organic compounds
Est. expiryDec 17, 2035(~9.4 yrs left)· nominal 20-yr term from priority
Inventors:Daniel Gubler
A61K 8/0216A61K 31/56A61B 2503/42A61B 5/165A61Q 13/00A61K 8/30A61B 2562/0295A61B 5/4011A61K 2800/87A61K 9/70A61B 5/1477A61P 25/00
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention includes an apparatus and method for aiding mood, emotion, or physiological state comprising: a substrate that is capable of capturing or absorbing one or more organic compounds from a subject having a first physiologic or emotional state at a first time; and an element that is capable of controlling the capture of the one or more organic compounds at a first time, or the release of the one or more organic compounds from the substrate at a second time, wherein exposure to an effective amount of the organic compounds changes the mood, emotion, or physiological state of the subject.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of isolating volatile organic compounds (VOCs) that emanate through skin of a subject, comprising:
placing a substrate in close proximity to the skin of the subject; capturing VOCs emanating from the skin of the subject onto the substrate; and isolating the captured VOCs from the substrate.
2 . The method of claim 1 , wherein the substrate is an activated carbon strip, a natural fiber, a synthetic fiber, a cellulose, a polymer, a carbon impregnated fiber, a mesh, a filter, a solid-phase microextraction fiber, a dried leaf or lichen, or a cotton gauze.
3 . The method of claim 1 , wherein the substrate is worn close to the body of the subject.
4 . The method of claim 1 , wherein the substrate is placed in close proximity to the skin of the subject for a period of time ranging from 1 to 8 hours.
5 . The method of claim 1 , wherein the VOCs are indicative of an emotional state, a physiological state, or a disease state.
6 . The method of claim 1 , wherein the VOCs are sex pheromones, alarm pheromones, modulator pheromones, trail pheromones, or signature odors.
7 . The method of claim 1 , wherein the subject is a human.
8 . The method of claim 1 , wherein isolating the captured VOCs comprises rinsing the substrate with a solvent to release the captured VOCs.
9 . A method of isolating volatile organic compounds (VOCs) that are captured on a substrate, comprising:
providing a substrate having VOCs captured thereon; and rinsing the substrate with an organic solvent to release captured VOCs, thereby isolating VOCs.
10 . The method of claim 9 , wherein the organic solvent is dichloromethane.
11 . The method of claim 9 , wherein the substrate is an activated carbon strip, a natural fiber, a synthetic fiber, a cellulose, a polymer, a carbon impregnated fiber, a mesh, a filter, a solid-phase microextraction fiber, a dried leaf or lichen, or a cotton gauze.
12 . The method of claim 9 , wherein the VOCs are indicative of an emotional state, a physiological state, or a disease state.
13 . The method of claim 9 , wherein the VOCs are sex pheromones, alarm pheromones, modulator pheromones, trail pheromones, or signature odors.
14 . A method of diagnosing an emotional state, a physiological state, or a disease state of a subject, comprising:
placing a substrate in close proximity to the subject, wherein the substrate is capable of capturing volatile organic compounds (VOCs); capturing VOCs on the substrate, wherein the VOCs emanate from the subject; rinsing the substrate with an organic solvent to release captured VOCs; analyzing the released VOCs; and comparing the released VOCs to VOCs known to be indicative of an emotional state, a physiological state, or a disease state, wherein the emotional state, physiological state, or disease state is determined when a released VOC generates a match with a known VOC that is identified as being indicative of the emotional state, physiological state, or disease state.
15 . The method of claim 14 , wherein the released VOCs are analyzed using gas chromatography mass spectrometry (GC-MS).
16 . The method of claim 15 , wherein the GC-MS generates a GC-MS spectrum that is compared with a GC-MS of a subject before a condition and is compared to a GC-MS of a subject after a condition.
17 . The method of claim 15 , wherein the GC-MS generates a GC-MS spectrum that is compared to a GC-MS from a healthy individual.
18 . The method of claim 14 , wherein the emotional state or physiological state is fear, stress, depression, happiness, confidence, ovulation, lactation, working out, sports activity, sexual activity, a wedding, a christening, a party, a business trip, a vacation, rock climbing, sky diving, roller coaster, bungee jumping, or cliff jumping.
19 . The method of claim 14 , wherein the disease state is diabetes, high cholesterol, cancer, liver disease, Alzheimer's disease, or schizophrenia.
20 . The method of claim 14 , wherein the substrate is an activated carbon strip, a natural fiber, a synthetic fiber, a cellulose, a polymer, a carbon impregnated fiber, a mesh, a filter, a solid-phase microextraction fiber, a dried leaf or lichen, or a cotton gauze.
21 . The method of claim 14 , wherein the VOCs emanate from breath or skin of a subject.
22 . The method of claim 14 , wherein the substrate is placed in close proximity to skin of the subject for a period of time ranging from 1 to 8 hours.
23 . The method of claim 14 , wherein the subject is a human.
24 . The method of claim 14 , wherein the organic solvent is dichloromethane.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.